Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-arm, Open-label, Long-term Follow-up Safety Study of Selexipag in Participants Who Participated in a Previous Selexipag Study

NCT04565990 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT04565990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04565990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-arm, Open-label, Long-term Follow-up Safety Study of Selexipag in Participants Who Participated in a Previous Selexipag Study
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
May 3, 2021
Completion date
November 10, 2023
Enrollment
43 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pulmonary